Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6

Peptides

Volumn 32, Issue 6, 2011, Pages 1187-1192

  Kantyka, Tomasz ^a,b   Fischer, Jan ^a   Wu, Zhihong ^a   Declercq, Wim ^c,d   Reiss, Karina ^a   Schröder, Jens Michael ^a   Meyer Hoffert, Ulf ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Atopic dermatitis; Epidermal barrier; Prostate cancer; Protease inhibitor

Indexed keywords

APROTININ; CASPASE 14; CHROMOGENIC SUBSTRATE; KALLIKREIN; KALLIKREIN 1; KALLIKREIN 11; KALLIKREIN 12; KALLIKREIN 13; KALLIKREIN 14; KALLIKREIN 3; KALLIKREIN 4; KALLIKREIN 5; KALLIKREIN 6; NEUROPSIN; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; INHIBITION KINETICS; MICHAELIS CONSTANT; PRIORITY JOURNAL; PROTEIN HYDROLYSIS;

AMINO ACID SEQUENCE; CASPASE 14; CHROMOGENIC COMPOUNDS; ENZYME ACTIVATION; HUMANS; KALLIKREINS; KINETICS; MOLECULAR SEQUENCE DATA; PROTEINASE INHIBITORY PROTEINS, SECRETORY; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SERINE PROTEINASE INHIBITORS; SKIN; SOLUTIONS; SPECTROPHOTOMETRY; SUBSTRATE SPECIFICITY;

EID: 79957981240     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.03.009     Document Type: Article

References (30)

1. A.J. Barrett, D.P. Tolle, and N.D. Rawlings Managing peptidases in the genomic era Biol Chem 384 2003 873 882 (Pubitemid 36874501)
2. N. Beaufort, K. Plaza, D. Utzschneider, A. Schwarz, J.M. Burkhart, and S. Creutzburg Interdependence of kallikrein-related peptidases in proteolytic networks Biol Chem 391 2010 581 587
3. K. Bennett, R. Callard, W. Heywood, J. Harper, A. Jayakumar, and G.L. Clayman New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI J Proteome Res 9 2010 4289 4294
4. C.A. Borgono, J.A. Gavigan, J. Alves, B. Bowles, J.L. Harris, and G. Sotiropoulou Defining the extended substrate specificity of kallikrein 1-related peptidases Biol Chem 388 2007 1215 1225 (Pubitemid 350059617)
5. C.A. Borgono, I.P. Michael, N. Komatsu, A. Jayakumar, R. Kapadia, and G.L. Clayman A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation J Biol Chem 282 2007 3640 3652 (Pubitemid 47084449)
6. M. Brattsand, K. Stefansson, T. Hubiche, S.K. Nilsson, and T. Egelrud SPINK9: a selective, skin-specific Kazal-type serine protease inhibitor J Invest Dermatol 129 2009 1656 1665
7. M. Brattsand, K. Stefansson, C. Lundh, Y. Haasum, and T. Egelrud A proteolytic cascade of kallikreins in the stratum corneum J Invest Dermatol 124 2005 198 203 (Pubitemid 40100969)
8. A. Briot, C. Deraison, M. Lacroix, C. Bonnart, A. Robin, and C. Besson Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome J Exp Med 206 2009 1135 1147
9. C. Caubet, N. Jonca, M. Brattsand, M. Guerrin, D. Bernard, and R. Schmidt Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7 J Invest Dermatol 122 2004 1235 1244 (Pubitemid 38651099)
10. M. Debela, P. Goettig, V. Magdolen, R. Huber, N.M. Schechter, and W. Bode Structural basis of the zinc inhibition of human tissue kallikrein 5 J Mol Biol 373 2007 1017 1031 (Pubitemid 47498441)
11. G. Denecker, E. Hoste, B. Gilbert, T. Hochepied, P. Ovaere, and S. Lippens Caspase-14 protects against epidermal UVB photodamage and water loss Nat Cell Biol 9 2007 666 674 (Pubitemid 47214729)
12. C. Deraison, C. Bonnart, F. Lopez, C. Besson, R. Robinson, and A. Jayakumar LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction Mol Biol Cell 18 2007 3607 3619 (Pubitemid 47378698)
13. T. Egelrud, M. Brattsand, P. Kreutzmann, M. Walden, K. Vitzithum, and U.C. Marx hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6 Br J Dermatol 153 2005 1200 1203 (Pubitemid 41779577)
14. C Kapadia, M.C. Ghosh, L. Grass, and E.P. Diamandis Human kallikrein 13 involvement in extracellular matrix degradation Biochem Biophys Res Commun 323 2004 1084 1090 (Pubitemid 39243429)
15. C. Kapadia, G.M. Yousef, A.A. Mellati, A. Magklara, G.A. Wasney, and E.P. Diamandis Complex formation between human kallikrein 13 and serum protease inhibitors Clin Chim Acta 339 2004 157 167 (Pubitemid 37542467)
16. T. Kirihara, K. Matsumoto-Miyai, Y. Nakamura, T. Sadayama, S. Yoshida, and S. Shiosaka Prolonged recovery of ultraviolet B-irradiated skin in neuropsin (KLK8)-deficient mice Br J Dermatol 149 2003 700 706 (Pubitemid 37411989)
17. B. Klucky, R. Mueller, I. Vogt, S. Teurich, B. Hartenstein, and K. Breuhahn Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion Cancer Res 67 2007 8198 8206 (Pubitemid 47395156)
18. N. Komatsu, K. Saijoh, A. Jayakumar, G.L. Clayman, M. Tohyama, and Y. Suga Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients J Invest Dermatol 128 2008 1148 1159 (Pubitemid 351543199)
19. H.J. Magert, L. Standker, P. Kreutzmann, H.D. Zucht, M. Reinecke, and C.P. Sommerhoff LEKTI, a novel 15-domain type of human serine proteinase inhibitor J Biol Chem 274 1999 21499 21502
20. N. Memari, W. Jiang, E.P. Diamandis, and L.Y. Luo Enzymatic properties of human kallikrein-related peptidase 12 (KLK12) Biol Chem 388 2007 427 435 (Pubitemid 46514693)
21. N. Mertens, E. Remaut, and W. Fiers Versatile, multi-featured plasmids for high-level expression of heterologous genes in Escherichia coli: overproduction of human and murine cytokines Gene 164 1995 9 15
22. U. Meyer-Hoffert, Z. Wu, T. Kantyka, J. Fischer, T. Latendorf, and B. Hansmann Isolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidases J Biol Chem 285 2010 32174 32181
23. U. Meyer-Hoffert, Z. Wu, and J.M. Schroder Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor PLoS One 4 2009 e4372
24. O. Ryu, J.C. Hu, Y. Yamakoshi, J.L. Villemain, X. Cao, and C. Zhang Porcine kallikrein-4 activation, glycosylation, activity, and expression in prokaryotic and eukaryotic hosts Eur J Oral Sci 110 2002 358 365
25. N.M. Schechter, E.J. Choi, Z.M. Wang, Y. Hanakawa, J.R. Stanley, and Y. Kang Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI) Biol Chem 386 2005 1173 1184 (Pubitemid 41705372)
26. J.L. Shaw, and E.P. Diamandis Distribution of 15 human kallikreins in tissues and biological fluids Clin Chem 53 2007 1423 1432 (Pubitemid 47206338)
27. K. Stefansson, M. Brattsand, A. Ny, B. Glas, and T. Egelrud Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum Biol Chem 387 2006 761 768 (Pubitemid 43964798)
28. K. Stefansson, M. Brattsand, D. Roosterman, C. Kempkes, G. Bocheva, and M. Steinhoff Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases J Invest Dermatol 128 2008 18 25 (Pubitemid 350249381)
29. S.A. Stephenson, K. Verity, L.K. Ashworth, and J.A. Clements Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4 J Biol Chem 274 1999 23210 23214
30. G.M. Yousef, A. Magklara, and E.P. Diamandis KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer Genomics 69 2000 331 341